Margusino-Framiñán, LuisFernández-Llamazares, Cecilia M.Negro-Vera, EvaTortajada Goitia, BegoñaLizeaga, GarbiñeMercadal-Orfila, GabrielAlmeida-González, CarmenMorillo-Verdugo, Ramón2022-05-262022-05-262021-12-31Margusino-Framiñán L, Fernández-Llamazares CM, Negro.Vera E, Tortajada-Goitia B, Lizeaga G, Mercadal-Orfila G, et al. Outpatients' opinion and experience regarding telepharmacy during the COVID-19 pandemic: the Enopex Project. J Multidiscip Healthc. 2021;14:36211178-2390http://hdl.handle.net/2183/30761[Abstract] Background: Telepharmacy, as a remote pharmaceutical care procedure, is being used worldwide during the COVID-19 pandemic, with the aim of preserving the health of patients and professionals. Its future development should incorporate the assessment of patient perception, but no research study has investigated it. Objective: The objective was to poll the opinions and experiences of outpatients with telepharmacy through a purpose-developed questionnaire and to assess it's quality through an internal validity and reliability analysis. Methods: Cross-sectional observational study of adult patients who used telepharmacy services during the COVID-19 lockdown period in Spain. The subjects answered a 24-item questionnaire, after giving their informed consent. Place of delivery, informed pharmacotherapeutic follow-up, opinion about telepharmacy, future development, ethics/satisfaction, and coordination constituted the six questionnaire categories. After assessing the adequate sample size with the Kaiser-Meyer-Olkin test, the Bartlett sphericity test analyzed the validity of the questionnaire. The intraclass correlation coefficient and Cronbach's α coefficient calculations verified the reliability and internal consistency. Results: A total of 9442 interviews were administered to patients from 81 hospitals, of which 8079 were valid (52.8% female). A 54.1% were aged between 41-65 years; 42.7% had been in treatment for more than 5 years; 42.8% lived between 6-31 miles from the hospital. As many as 96.7% of patients were "satisfied" or "very satisfied" with telepharmacy, 97.5% considering it complementary to their usual follow-up; 55.9% expressed a preference for being followed up face to face when visiting the hospital. 75.6% said they had rather receive their medication at home. The sample size obtained was deemed appropriate [the Kaiser-Meyer-Olkin test (0.789) and Bartlett's sphericity test (p<0.005)]. The reliability analysis resulted in a Cronbach α = 0.7. Conclusion: Patients have shown high satisfaction with telepharmacy and the ENOPEX questionnaire is a tool with sufficient validity and reliability to be used in the evaluation of the care that patients receive through telepharmacy.engAtribución-NoComercial 3.0 Españahttp://creativecommons.org/licenses/by-nc/3.0/es/CoronavirusHealthcare quality assessmentHospital pharmacy servicesPatient reported experience measuresPharmaceutical careTelepharmacyjournal articleopen access